Intervention group | P | Reference group | P | |
---|---|---|---|---|
Median (IQR) | Median (IQR) | |||
VAS/pain | ||||
Baseline | 51 (36–62) n = 195 | 60 (50–70) n = 69 | ||
3 months | 37 (21–54) n = 169 | < 0.001 * | 62 (37–71) n = 49 | 0.668 |
12 months | 38 (21–57) n = 127 | < 0.001 * | ||
EQ-5D | ||||
Baseline | 0.73 (0.62–0.80) n = 193 | 0.66 (0.16–0.73) n = 69 | ||
3 months | 0.73 (0.69–0.80) n = 169 | < 0.001 * | 0.52 (0.09–0.73) n = 49 | 0.177 |
12 months | 0.73 (0.69–0.80) n = 127 | 0.009 * | ||
ASES/other | ||||
Baseline | 68 (53–80) n = 193 | 61 (48–70) n = 69 | ||
3 months | 76 (61–86) n = 169 | < 0.001 * | 56 (46–81) n = 47 | 0.937 |
12 months | 71 (55–83) n = 125 | 0.409 | ||
ASES/pain | ||||
Baseline | 60 (46–76) n = 193 | 46 (38–62) n = 69 | ||
3 months | 74 (56–86) n = 169 | < 0.001 * | 50 (32–70) n = 47 | 0.391 |
12 months | 68 (46–84) n = 123 | 0.109 |